- Home
- SENEA vs OPK Comparison
SENEA vs OPK Comparison
Compare SENEA & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SENEA | OPK |
|---|---|---|
| Founded | 1949 | 2006 |
| Country | United States | United States |
| Employees | 6895 | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 908.7M | 921.2M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | SENEA | OPK |
|---|---|---|
| Price | $144.50 | $1.23 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $1.60 |
| AVG Volume (30 Days) | 78.9K | ★ 2.2M |
| Earning Date | 06-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $606,879,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.24 |
| P/E Ratio | $13.21 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $87.99 | $0.98 |
| 52 Week High | $167.52 | $1.60 |
Technical Indicators
Market Signals| Indicator | SENEA | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 51.41 | 65.67 |
| Support Level | $138.19 | $1.12 |
| Resistance Level | $148.36 | $1.27 |
| Average True Range (ATR) | 5.61 | 0.04 |
| MACD | 0.66 | 0.01 |
| Stochastic Oscillator | 61.31 | 96.88 |
Price Performance
Historical ComparisonAbout SENEA Seneca Foods Corp.
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.